SlideShare a Scribd company logo
1 of 27
Uncomplicated Sepsis, Severe Sepsis,

          & Septic Shock

        Susie Brishaber, RN
           August, 2012
   All Sepsis categories hold    Tachycardia (HR > 90)
    the same general clinical     Warm skin, possibly
    manifestations                 rash
       Hyperthermia (>38         Generalized Weakness
        degrees Celsius)          High WBC count
       Hypothermia (<36           (>12,000 µL-1)
        degrees Celsius)          Low WBC count
       Difficulty Breathing       (<4,0000 µL-1)
        (Tachypnea, >20 BPM)      Coagulation Imbalance
   Severe Sepsis – in addition to general clinical
    manifestations
   Is categorized by having one or more vital organs affected
    ◦ Lungs
    ◦ Heart
    ◦ Kidney
    ◦ Liver
    ◦ Central Nervous System
   Severe Sepsis –
      RENAL SYSTEM:
      Serum Creatinine level > /= 177 µ mol/L
      Oliguria (Output of < 0.5 ml/Kg/ hr., if adequate fluid resuscitation)


      CARDIOVASCULAR:
      Hypotension (Systolic < 90 mm Hg, Diastolic < 60mm Hg)
      Atria or Ventricular Rhythms
      MAP < 65
   LIVER
    ◦ Jaundice
    ◦ Increased levels of Hepatic Enzymes
        AST > 48 U/L
        ALT > 55 U/L
        PT > 10.8 seconds
        INR > 1.5
        PTT > 60 seconds
   IMMUNILOGICAL
    ◦ Nosocomial Infection development
    ◦ Increase Leukocytosis
    ◦ Fever (>100.0)
   NEUROLOGICAL
    ◦ Altered LOC
    ◦ Altered CNS function
    ◦ Encelopathy

   ENDOCRINE
    ◦ Hyperglycemia (in absence of Diabetes, >140)
    ◦ Weight loss
    ◦ Cachexia (Muscle atrophy)
 Skin

 ◦ Poor tissue perfusion
   Lactic Acid Level (>5 mmol/L)
   Edema (With fluid management)
   Activity Intolerance
   Acute Pain
   Anxiety
   Chronic Pain
   Decreased Cardiac Output
   Impaired Gas Exchange
   Process of PES
   P = Problem statement/diagnostic label/definition
   E = Etiology/related factors/causes
   S = Defining characteristics/signs and symptoms
Etiology/Related
      Factors/Causes


   Sepsis can be caused
    from many different
  infections in different
areas of the body. With
              each body
  system, bacteria has a
  place to grow if given
             the chance.
   The lungs are the
    major source of
    infection in severe
    sepsis (especially
    with hospital-
    acquired
    infections), with
    sepsis usually
    associated with
    pneumonia.
   Infection in the
    abdomen, eg, appendicitis,
     bowel
    problems, gallbladder
    infections. When the outer
    surface of the abdominal
    organs (called the
    peritoneum) is involved in
    the infection, it is called
    "peritonitis.“
   Diabetic patients are also
    at increased risk of urinary
    infections leading to
    sepsis. Sometimes this is
    referred to as "urosepsis"
    which just refers to sepsis
    related to a urinary tract
    infection.
   (Surviving Sepsis
    Campaign)
   Bacteria enter the skin
    through wounds and skin
    inflammations; they also
    enter the skin and blood
    through an opening
    provided by intravenous
    ("IV") catheters (small
    tubes for dripping fluids),
    which are required for the
    administration of fluids
    and/or medicines.
   Surviving Sepsis Campaign
    ◦   Setting Aims
    ◦   Establishing Measures
    ◦   Creating a Protocol
    ◦   Enhancing Reliability
    ◦   Testing Changes
   The goal is to perform all indicated tasks 100%of the
    time within the first 6 hours of identification of severe
    sepsis.
   The tasks are:
   1. Measure serum lactate
   2. Obtain blood cultures prior to antibiotic
    administration
   3. Administer broad-spectrum antibiotic, within 3 hrs.
    of ED admission and within 1 hour of non-ED
    admission
   4. In the event of hypotension and/or a serum lactate > 4
    mmol/L
    ◦ a. Deliver an initial minimum of 20 ml/kg of crystalloid or an
      equivalent
    ◦ b. Apply vasopressors for hypotension not responding to initial fluid
      resuscitation to maintain mean arterial pressure (MAP) > 65 mm Hg
   5. In the event of persistent hypotension despite fluid
    resuscitation (septic shock) and/or lactate > 4mmol/L
    ◦ a. Achieve a central venous pressure (CVP) of > 8 mm Hg
    ◦ b. Achieve a central venous oxygen saturation (ScvO2) > 70 % or
      mixed venous oxygen saturation (SvO2) > 65 %
                                  (Surviving Sepsis Campaign)
   Efforts to accomplish these goals should begin
    immediately, but these items may be completed within 24
   hours of presentation for patients with severe sepsis or septic
    shock.
   1. Administer low-dose steroids for septic shock in accordance
    with a standardized ICU policy. If not administered, document
    why the patient did not qualify for low-dose steroids based
    upon the standardized protocol.
   2. Administer drotrecogin alfa (activated) in accordance
    with a standardized ICU policy. If not
    administered, document why the patient did not qualify
    for drotrecogin alfa (activated).
   3. Maintain glucose control > 70, but < 150 mg/dl
   4. Maintain a median inspiratory plateau pressure (IPP)* <
    30 cm H2O for mechanically ventilated patients
   Apache II Score
   Measure Serum Lactate Levels
   Blood cultures
   Initiate IV Antibiotic Therapy
   Treatment of Hypotension
   Keep oxygen saturation stable/Ventilator
 Broad  Spectrum Antibiotics should
  be administered within 3 hours of
  suspected Severe Sepsis or Septic
  Shock
 Blood cultures need to be drawn
  before antibiotics are started
   Treat Hypotension
   If presenting with hypotension and/or lactate level of
    >4 mmol/L give 20mL/kg of crystalloid solution
    ◦ Lactated Ringer’s
    ◦ Normal saline

   Fluid administration to reach a CVP of >8mm Hg
   When patients do not respond to initial fluid
    resuscitation, use vasopressor therapy to maintain a
    MAP > 65mm Hg
    ◦ Dopamine
    ◦ Norepinephrine

    ◦ Titrate according to protocol
   Blood cultures should be re-evaluated in 48
    hours to determine specific antibiotic therapy
   Continue monitoring patient’s vital signs till
    hemodynamically stable
   Follow protocols for PICC dressing, hand
    washing, dressing changes, and peri care
   http://www.survivingsepsis.org/What_You_Should_Kn
    ow/Pages/default.aspx
   http://www.nigms.nih.gov/Education/factsheet_sepsis.h
    tm
   http://www.merckmanuals.com/professional/critical_ca
    re_medicine/sepsis_and_septic_shock/sepsis_and_septi
    c_shock.html
   http://www.merckmanuals.com/home/infections/bacter
    emia_sepsis_and_septic_shock/sepsis_and_septic_shoc
    k.html
   http://www.survivingsepsis.org/SiteCollectionDocumen
    ts/Pathophysiology%20of%20Sepsis%20Phil(2).pdf
   Surviving Sepsis Campaign, 2010
   Dellinger, P., Levy, M., Carlet, J., Bion, J., Parker, M.,
    Jaeschke, R.,et al (2008). Surviving Sepsis Campaign:
    International guidelines for management of severe
    sepsis and septic shock. Critical Care Medicine, 1-33,
    DOI: 10.1097/01.CCM.0000298158.12101.41.
   Wesley, E., Kleinpell, R., Goyette, R., (2003).
    Advances in the understanding of clinical
    manifestations and therapy of severe sepsis: An update
    for critical care nurses. American Journal of Critical
    Care, 12(2),120-133. Retrieved from
    http://ajcc.aacnjournals.org/content/12/2/1
    20.full

More Related Content

What's hot

Sepsis 05 12 definitief
Sepsis 05 12 definitiefSepsis 05 12 definitief
Sepsis 05 12 definitief
barbrabackus
 
Sepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated managementSepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated management
ahad80a
 

What's hot (20)

Sepsis Treatment
Sepsis TreatmentSepsis Treatment
Sepsis Treatment
 
Sepsis caster
Sepsis casterSepsis caster
Sepsis caster
 
Sepsis and septic shock
Sepsis  and septic shockSepsis  and septic shock
Sepsis and septic shock
 
Known case of type 2 Diabetes Mellitus with hypertension with urosepsis
Known case of type 2 Diabetes Mellitus with hypertension with urosepsisKnown case of type 2 Diabetes Mellitus with hypertension with urosepsis
Known case of type 2 Diabetes Mellitus with hypertension with urosepsis
 
Sepsis 05 12 definitief
Sepsis 05 12 definitiefSepsis 05 12 definitief
Sepsis 05 12 definitief
 
Sepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated managementSepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated management
 
20201118 sepsis and septic shock
20201118 sepsis and septic shock20201118 sepsis and septic shock
20201118 sepsis and septic shock
 
Best Practice in Sepsis
Best Practice in SepsisBest Practice in Sepsis
Best Practice in Sepsis
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Sepsis
Sepsis Sepsis
Sepsis
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis Management
Sepsis ManagementSepsis Management
Sepsis Management
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
 
Sepsis 3.0
Sepsis 3.0Sepsis 3.0
Sepsis 3.0
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Sepsis ass
Sepsis assSepsis ass
Sepsis ass
 

Similar to Sepsis powerpoints

Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
haley crise
 
Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
haley crise
 
Surviving Sepsis
Surviving SepsisSurviving Sepsis
Surviving Sepsis
Max Kyi
 
Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012
Sourabh Pathak
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
Kit GenSx
 

Similar to Sepsis powerpoints (20)

Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
 
Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
 
Surviving Sepsis
Surviving SepsisSurviving Sepsis
Surviving Sepsis
 
Identification and recognition of sepsis
Identification and recognition of sepsisIdentification and recognition of sepsis
Identification and recognition of sepsis
 
Identification and recognition of sepsis
Identification and recognition of sepsisIdentification and recognition of sepsis
Identification and recognition of sepsis
 
Sepsis By Dr Muhammad Akram Khan Qaim Khani
Sepsis By Dr Muhammad Akram Khan Qaim KhaniSepsis By Dr Muhammad Akram Khan Qaim Khani
Sepsis By Dr Muhammad Akram Khan Qaim Khani
 
Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012
 
Sepsis
SepsisSepsis
Sepsis
 
Mss
MssMss
Mss
 
Dr hamada alsedawy sepsis and aki
Dr hamada alsedawy   sepsis and akiDr hamada alsedawy   sepsis and aki
Dr hamada alsedawy sepsis and aki
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
DengueManagementinED.pptx
DengueManagementinED.pptxDengueManagementinED.pptx
DengueManagementinED.pptx
 
Severe Sepsis And Septic Shock
Severe Sepsis And Septic ShockSevere Sepsis And Septic Shock
Severe Sepsis And Septic Shock
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
SEPSIS AND SEPTIC SHOCK.pptx
SEPSIS AND SEPTIC SHOCK.pptxSEPSIS AND SEPTIC SHOCK.pptx
SEPSIS AND SEPTIC SHOCK.pptx
 
Sepsis 2009 update final
Sepsis 2009 update finalSepsis 2009 update final
Sepsis 2009 update final
 
Perforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic ShockPerforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic Shock
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
 
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE  EMERGENCIES.pptxSEPSIS MANGEMENT IN THE  EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
 
Sepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptxSepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptx
 

Recently uploaded

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 

Recently uploaded (20)

Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 

Sepsis powerpoints

  • 1. Uncomplicated Sepsis, Severe Sepsis, & Septic Shock Susie Brishaber, RN August, 2012
  • 2. All Sepsis categories hold  Tachycardia (HR > 90) the same general clinical  Warm skin, possibly manifestations rash  Hyperthermia (>38  Generalized Weakness degrees Celsius)  High WBC count  Hypothermia (<36 (>12,000 µL-1) degrees Celsius)  Low WBC count  Difficulty Breathing (<4,0000 µL-1) (Tachypnea, >20 BPM)  Coagulation Imbalance
  • 3. Severe Sepsis – in addition to general clinical manifestations  Is categorized by having one or more vital organs affected ◦ Lungs ◦ Heart ◦ Kidney ◦ Liver ◦ Central Nervous System
  • 4. Severe Sepsis –  RENAL SYSTEM:  Serum Creatinine level > /= 177 µ mol/L  Oliguria (Output of < 0.5 ml/Kg/ hr., if adequate fluid resuscitation)  CARDIOVASCULAR:  Hypotension (Systolic < 90 mm Hg, Diastolic < 60mm Hg)  Atria or Ventricular Rhythms  MAP < 65
  • 5. LIVER ◦ Jaundice ◦ Increased levels of Hepatic Enzymes  AST > 48 U/L  ALT > 55 U/L  PT > 10.8 seconds  INR > 1.5  PTT > 60 seconds  IMMUNILOGICAL ◦ Nosocomial Infection development ◦ Increase Leukocytosis ◦ Fever (>100.0)
  • 6. NEUROLOGICAL ◦ Altered LOC ◦ Altered CNS function ◦ Encelopathy  ENDOCRINE ◦ Hyperglycemia (in absence of Diabetes, >140) ◦ Weight loss ◦ Cachexia (Muscle atrophy)
  • 7.  Skin ◦ Poor tissue perfusion  Lactic Acid Level (>5 mmol/L)  Edema (With fluid management)
  • 8. Activity Intolerance  Acute Pain  Anxiety  Chronic Pain  Decreased Cardiac Output  Impaired Gas Exchange
  • 9. Process of PES  P = Problem statement/diagnostic label/definition  E = Etiology/related factors/causes  S = Defining characteristics/signs and symptoms
  • 10. Etiology/Related Factors/Causes Sepsis can be caused from many different infections in different areas of the body. With each body system, bacteria has a place to grow if given the chance.
  • 11. The lungs are the major source of infection in severe sepsis (especially with hospital- acquired infections), with sepsis usually associated with pneumonia.
  • 12. Infection in the abdomen, eg, appendicitis, bowel problems, gallbladder infections. When the outer surface of the abdominal organs (called the peritoneum) is involved in the infection, it is called "peritonitis.“  Diabetic patients are also at increased risk of urinary infections leading to sepsis. Sometimes this is referred to as "urosepsis" which just refers to sepsis related to a urinary tract infection.  (Surviving Sepsis Campaign)
  • 13. Bacteria enter the skin through wounds and skin inflammations; they also enter the skin and blood through an opening provided by intravenous ("IV") catheters (small tubes for dripping fluids), which are required for the administration of fluids and/or medicines.
  • 14. Surviving Sepsis Campaign ◦ Setting Aims ◦ Establishing Measures ◦ Creating a Protocol ◦ Enhancing Reliability ◦ Testing Changes
  • 15.
  • 16. The goal is to perform all indicated tasks 100%of the time within the first 6 hours of identification of severe sepsis.  The tasks are:  1. Measure serum lactate  2. Obtain blood cultures prior to antibiotic administration  3. Administer broad-spectrum antibiotic, within 3 hrs. of ED admission and within 1 hour of non-ED admission
  • 17. 4. In the event of hypotension and/or a serum lactate > 4 mmol/L ◦ a. Deliver an initial minimum of 20 ml/kg of crystalloid or an equivalent ◦ b. Apply vasopressors for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure (MAP) > 65 mm Hg  5. In the event of persistent hypotension despite fluid resuscitation (septic shock) and/or lactate > 4mmol/L ◦ a. Achieve a central venous pressure (CVP) of > 8 mm Hg ◦ b. Achieve a central venous oxygen saturation (ScvO2) > 70 % or mixed venous oxygen saturation (SvO2) > 65 % (Surviving Sepsis Campaign)
  • 18. Efforts to accomplish these goals should begin immediately, but these items may be completed within 24  hours of presentation for patients with severe sepsis or septic shock.  1. Administer low-dose steroids for septic shock in accordance with a standardized ICU policy. If not administered, document why the patient did not qualify for low-dose steroids based upon the standardized protocol.
  • 19. 2. Administer drotrecogin alfa (activated) in accordance with a standardized ICU policy. If not administered, document why the patient did not qualify for drotrecogin alfa (activated).  3. Maintain glucose control > 70, but < 150 mg/dl  4. Maintain a median inspiratory plateau pressure (IPP)* < 30 cm H2O for mechanically ventilated patients
  • 20. Apache II Score  Measure Serum Lactate Levels  Blood cultures  Initiate IV Antibiotic Therapy  Treatment of Hypotension  Keep oxygen saturation stable/Ventilator
  • 21.  Broad Spectrum Antibiotics should be administered within 3 hours of suspected Severe Sepsis or Septic Shock  Blood cultures need to be drawn before antibiotics are started
  • 22. Treat Hypotension  If presenting with hypotension and/or lactate level of >4 mmol/L give 20mL/kg of crystalloid solution ◦ Lactated Ringer’s ◦ Normal saline  Fluid administration to reach a CVP of >8mm Hg
  • 23. When patients do not respond to initial fluid resuscitation, use vasopressor therapy to maintain a MAP > 65mm Hg ◦ Dopamine ◦ Norepinephrine ◦ Titrate according to protocol
  • 24. Blood cultures should be re-evaluated in 48 hours to determine specific antibiotic therapy  Continue monitoring patient’s vital signs till hemodynamically stable  Follow protocols for PICC dressing, hand washing, dressing changes, and peri care
  • 25. http://www.survivingsepsis.org/What_You_Should_Kn ow/Pages/default.aspx  http://www.nigms.nih.gov/Education/factsheet_sepsis.h tm  http://www.merckmanuals.com/professional/critical_ca re_medicine/sepsis_and_septic_shock/sepsis_and_septi c_shock.html  http://www.merckmanuals.com/home/infections/bacter emia_sepsis_and_septic_shock/sepsis_and_septic_shoc k.html
  • 26. http://www.survivingsepsis.org/SiteCollectionDocumen ts/Pathophysiology%20of%20Sepsis%20Phil(2).pdf  Surviving Sepsis Campaign, 2010  Dellinger, P., Levy, M., Carlet, J., Bion, J., Parker, M., Jaeschke, R.,et al (2008). Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Critical Care Medicine, 1-33, DOI: 10.1097/01.CCM.0000298158.12101.41.
  • 27. Wesley, E., Kleinpell, R., Goyette, R., (2003). Advances in the understanding of clinical manifestations and therapy of severe sepsis: An update for critical care nurses. American Journal of Critical Care, 12(2),120-133. Retrieved from http://ajcc.aacnjournals.org/content/12/2/1 20.full